XML 207 R161.htm IDEA: XBRL DOCUMENT v3.24.0.1
Liabilities related to business combinations and to non-controlling interests - Summary of Movements in Liabilities Related to Business Combinations and to Non-Controlling Interests (Details)
€ in Millions, $ in Millions
 12 Months Ended
Dec. 31, 2023
EUR (€)
Dec. 31, 2022
EUR (€)
Dec. 31, 2021
EUR (€)
Dec. 31, 2022
USD ($)
Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]        
Beginning balance € 779 € 714 € 605  
New transactions 0 156 360  
Payments made (167) (136) (258)  
Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount) 114 5 (4)  
Other movements 0 0 (14)  
Currency translation differences (17) 40 25  
Ending balance 709 779 714  
Non-current liabilities related to business combinations and to non-controlling interests 501 674 577  
Current liabilities related to business combinations and to non-controlling interests 208 105 137  
Bayer contingent purchase consideration arising from the acquisition of Genzyme        
Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]        
Beginning balance 26 59 104  
New transactions 0 0 0  
Payments made (21) (29) (31)  
Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount) (5) (9) (18)  
Other movements 0 0 0  
Currency translation differences 0 5 4  
Ending balance 0 26 59  
MSD contingent consideration (European vaccines business)        
Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]        
Beginning balance 204 269 312  
New transactions 0 0 0  
Payments made (77) (79) (75)  
Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount) 0 14 26  
Other movements 0 0 0  
Currency translation differences 0 0 6  
Ending balance 127 204 269  
Shire contingent consideration arising from the acquisition of Translate Bio        
Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]        
Beginning balance 380 354 0  
New transactions 0 0 323  
Payments made 0 0 0  
Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount) 74 2 19  
Other movements 0 0 0  
Currency translation differences (13) 24 12  
Ending balance 441 380 354  
Amunix        
Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]        
Beginning balance 165 0 0  
New transactions 0 156 0  
Payments made (69) 0 0  
Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount) 45 (2) 0  
Other movements 0 0 0  
Currency translation differences (4) 11 0  
Ending balance 137 165 0  
Other        
Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]        
Beginning balance 4 32 189  
New transactions 0 0 37  
Payments made 0 (28) (152)  
Fair value remeasurements through profit or loss: (gain)/loss (including unwinding of discount) 0 0 (31)  
Other movements 0 0 (14)  
Currency translation differences 0 0 3  
Ending balance € 4 € 4 € 32  
Translate Bio        
Disclosure Of Liabilities Related To Business Combinations And To Noncontrolling Interests [line items]        
Contingent consideration liabilities | $       $ 382